Carcinoid syndrome classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(64 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Carcinoid syndrome}}
 
{{CMG}}{{AE}}{{PSD}}
{{CMG}}{{AE}}{{Anum}}{{PSD}}
==Overview==
==Overview==
Based on location of tumor, carcinoid tumor may be classified into either foregut, midgut or hindgut carcinoid tumors.
[[Gastroenteropancreatic]] [[neuroendocrine tumors]] are classified based on their origin from the [[embryonic]] divisions of the [[alimentary tract]] into [[foregut]] [[Bronchial|(bronchial]], [[stomach]]), [[midgut]] ([[small intestine]], [[appendix]], [[cecum]]) and [[hindgut]] ([[Colon|distal colon]], [[rectum]], [[genitourinary]]) [[Tumour|tumours.]]
 
==Classification==
==Classification==
Classification of carcinoid tumors is based generally on the location in the primitive gut that gives rise to the tumor-
*[[Gastroenterology|Gastroentero]]-[[pancreatic]] [[Neuroendocrine tumor|neuroendocrine tumors]] are classified based on their origin from the [[embryonic]] divisions of the [[alimentary tract]]:
*Foregut carcinoid tumors
#[[Foregut]] [[Bronchial|(bronchial]], [[stomach]])
*Midgut carcinoid tumors
#[[Midgut]] ([[small intestine]], [[appendix]], [[cecum]])
*Hindgut carcinoid tumors
#[[Hindgut]] ([[Colon|distal colon]], [[rectum]], [[genitourinary]])
*Gasroenteropancreatic- [[neuroendocrine tumor]] produce a number of [[Secretory component|secretory]] products, resulting in a wide range of clinica[[Symptoms|l symptoms.]]<ref name="pmid29260133">{{cite journal |vauthors=Büyükaşık K, Arı A, Tatar C, Akçe B, Sevinç MM, Sarı S, Paşaoğlu E, Bektaş H |title=Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: A retrospective evaluation of 42 cases |journal=Turk J Surg |volume=33 |issue=4 |pages=279–283 |date=2017 |pmid=29260133 |doi=10.5152/UCD.2017.3685 |url=}}</ref> <ref name="pmid26911175">{{cite journal |vauthors=Davies L, Weickert MO |title=Gastroenteropancreatic neuroendocrine tumours: an overview |journal=Br J Nurs |volume=25 |issue=4 |pages=S12–5 |date=2016 |pmid=26911175 |doi=10.12968/bjon.2016.25.4.S12 |url=}}</ref><ref name="pmid21311954">{{cite journal |vauthors=Oberg K, Castellano D |title=Current knowledge on diagnosis and staging of neuroendocrine tumors |journal=Cancer Metastasis Rev. |volume=30 Suppl 1 |issue= |pages=3–7 |date=March 2011 |pmid=21311954 |doi=10.1007/s10555-011-9292-1 |url=}}</ref>
*[[Midgut]] [[gastrointestinal]] tract [[neuroendocrine tumor|neuroendocrine tumors]] produce [[serotonin]] and other [[vasoactive]] [[substances]] that causes the manifestations of typical [[Carcinoid Syndrome|carcinoid syndrome.]]
*[[Lung]] [[neuroendocrine tumors]] produce less quantities of [[serotonin]].
*[[Carcinoid Syndrome|Carcinoid syndrome]] is caused less commonly by [[lung]] [[neuroendocrine tumor]]  and most often by [[tumors]] of large [[size]] (>5 cm).


Carcinoid tumours of the lung can be divided into the two groups dependent on histology as follows:<ref> Carcinoid tumours of the lung
. Radiopaedia. http://radiopaedia.org/articles/carcinoid-tumours-of-the-lung Accessed on September 22, 2015</ref>
*typical carcinoid tumours of the lung
*atypical carcinoid tumours of the lung


Carcinoid tumours of the lung can also be divided into two groups dependent on location as follows:
{{Carcinoid syndrome}}
*Bronchial carcinoid tumours: central lesions
{| class="wikitable"
*Peripheral pulmonary carcinoid tumours: peripheral lesions
|+<big>Gastroenteropancreatic neuroendocrine tumors</big>
!
!'''[[Foregut]]'''
!'''[[Midgut]]'''
!'''[[Hindgut]]'''
|-
|'''Location'''
|
* [[Stomach]]
* [[Duodenum]]
* [[Bronchus]]
* [[Thymus]]
|
* [[Jejunum]]
* [[Ileum]]
* [[Appendix]]
* [[Ascending colon]]
|
* [[Transverse colon]]
* [[Descending colon]]
* [[Sigmoid colon]]
* [[Rectum]]
* [[Genitourinary]]
|-
|'''[[Hormones]] produced'''
|
* [[5-hydroxytryptophan]]
* [[Histamine]]
* [[Multiple polypeptides]]
|
* [[Serotonin]]
* [[Prostaglandins]]
* [[Polypeptides]]
|Variable
|-
|'''Possibility of [[carcinoid]] [[syndrome]]'''
|Rare, and atypical when it occurs
|Classic
|Rare
|}


==References==
==References==
Line 25: Line 65:
{{WS}}
{{WS}}


[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Types of cancer]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Pulmonology]]
[[Category:Hematology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Endocrinology]]
[[Category:Surgery]]

Latest revision as of 20:04, 1 May 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Anum Gull M.B.B.S.[2]Parminder Dhingra, M.D. [3]

Overview

Gastroenteropancreatic neuroendocrine tumors are classified based on their origin from the embryonic divisions of the alimentary tract into foregut (bronchial, stomach), midgut (small intestine, appendix, cecum) and hindgut (distal colon, rectum, genitourinary) tumours.

Classification

  1. Foregut (bronchial, stomach)
  2. Midgut (small intestine, appendix, cecum)
  3. Hindgut (distal colon, rectum, genitourinary)


Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome classification

CDC on Carcinoid syndrome classification

Carcinoid syndrome classification in the news

Blogs on Carcinoid syndrome classification

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome classification

Gastroenteropancreatic neuroendocrine tumors
Foregut Midgut Hindgut
Location
Hormones produced Variable
Possibility of carcinoid syndrome Rare, and atypical when it occurs Classic Rare

References

  1. ↑ Büyükaşık K, Arı A, Tatar C, Akçe B, Sevinç MM, Sarı S, Paşaoğlu E, Bektaş H (2017). "Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: A retrospective evaluation of 42 cases". Turk J Surg. 33 (4): 279–283. doi:10.5152/UCD.2017.3685. PMID 29260133.
  2. ↑ Davies L, Weickert MO (2016). "Gastroenteropancreatic neuroendocrine tumours: an overview". Br J Nurs. 25 (4): S12–5. doi:10.12968/bjon.2016.25.4.S12. PMID 26911175.
  3. ↑ Oberg K, Castellano D (March 2011). "Current knowledge on diagnosis and staging of neuroendocrine tumors". Cancer Metastasis Rev. 30 Suppl 1: 3–7. doi:10.1007/s10555-011-9292-1. PMID 21311954.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Carcinoid_syndrome_classification&oldid=1566105"